Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

Affiliations

• ¹ Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing, Medical University, No. 42 Baiziting, Nanjing, 210009, Jiangsu, People's Republic of China.
• ² Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing, Medical University, No. 42 Baiziting, Nanjing, 210009, Jiangsu, People's Republic of China. DrSainanHu@163.com.